YS Biopharma (YSBPW) Competitors $0.03 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock YSBPW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, and CLNNWShould you be buying YS Biopharma stock or one of its competitors? The main competitors of YS Biopharma include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), and Clene (CLNNW). These companies are all part of the "biotechnology" industry. YS Biopharma vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene YS Biopharma (NASDAQ:YSBPW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership. Does the media prefer YSBPW or ATNFW? In the previous week, YS Biopharma's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score. Company Overall Sentiment YS Biopharma Neutral 180 Life Sciences Neutral Is YSBPW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets YS BiopharmaN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has stronger valuation & earnings, YSBPW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioYS Biopharma$560.76MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryYS Biopharma beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Get YS Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for YSBPW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding YSBPW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart YSBPW vs. The Competition Export to ExcelMetricYS BiopharmaBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$237.82M$5.80B$10.16BDividend YieldN/A3.78%5.72%4.60%P/E RatioN/A40.4775.0426.40Price / SalesN/A4,764.58506.03174.59Price / CashN/A13.1925.8129.91Price / BookN/A129.5913.426.28Net IncomeN/A-$90.99M$3.29B$270.38M7 Day PerformanceN/A1.05%0.09%1.89%1 Month PerformanceN/A20.68%4.56%6.01%1 Year PerformanceN/A707.81%74.87%25.26% YS Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)YSBPWYS BiopharmaN/A$0.03flatN/AN/A$0.00$560.76M0.00865ATNFW180 Life SciencesN/A$0.18-7.1%N/A+1,107.9%$0.00N/A0.007Gap UpSXTPW60 Degrees PharmaceuticalsN/A$0.07+7.4%N/AN/A$0.00$641.41K0.002Gap DownDRTSWAlpha Tau MedicalN/A$0.31flatN/AN/A$0.00N/A0.0080APLMWApollomicsN/A$0.01+9.5%N/A+107.8%$0.00N/A0.0059News CoveragePositive NewsShort Interest ↓Gap DownBCTXWBriaCell TherapeuticsN/A$0.03+19.0%N/A-83.4%$0.00N/A0.008Gap UpCDIOWCardio DiagnosticsN/A$0.02-11.1%N/A-38.0%$0.00$19.51K0.007Positive NewsShort Interest ↓Gap UpCELUWCelularityN/A$0.06+34.1%N/A+173.2%$0.00$44.59M0.00220Positive NewsCEROWCERo TherapeuticsN/A$0.02-12.2%N/A+43.0%$0.00N/A0.008Positive NewsCINGWCingulateN/A$0.07+19.0%N/A-24.4%$0.00N/A0.0020Positive NewsGap UpCLNNWCleneN/A$0.03+10.8%N/A-49.2%$0.00$286K0.00100Positive NewsGap Down Related Companies and Tools Related Companies 180 Life Sciences Alternatives 60 Degrees Pharmaceuticals Alternatives Alpha Tau Medical Alternatives Apollomics Alternatives BriaCell Therapeutics Alternatives Cardio Diagnostics Alternatives Celularity Alternatives CERo Therapeutics Alternatives Cingulate Alternatives Clene Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:YSBPW) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share YS Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free YSBPW Stock Alerts